Pathological study of thyrotropin-secreting pituitary adenoma: Plurihormonality and medical treatment

Acta Neuropathologica

Volumn 108, Issue 2, 2004, Pages 147-153

  Teramoto, Akira ^a,b   Sanno, Naoko ^a,b   Tahara, Shigeyuki ^a,b   Osamura, Yoshiyuki R ^a,b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Growth hormone; Octreotide; Pit 1; Prolactin; TSH secreting adenoma

Indexed keywords

BROMOCRIPTINE; GROWTH HORMONE; OCTREOTIDE; PROLACTIN; SOMATOMEDIN C; THYROTROPIN; TRANSCRIPTION FACTOR PIT 1;

ACROMEGALY; ADULT; ARTICLE; CHIARI FROMMEL SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROTEIN LOCALIZATION; SECRETORY GRANULE; THYROTROPIN RELEASE; TRANSSPHENOIDAL HYPOPHYSECTOMY; TUMOR CELL; TUMOR VOLUME;

EID: 4344616510     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-004-0863-x     Document Type: Article

References (29)

1. Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP (1993) Cell type specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J. Clin Endocrinol Metab 77:1275-1280
2. Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A (1991) Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 72:477-483
3. Beck-Peccoz P, Piscitelli G, Amr S, Ballabio M, Bassetti M, Giannattasio G, Spada A, Nissim M, Weintraub BD, Faglia G (1986) Endocrine, biochemical and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH) and alpha-subunit: evidence for secretion of TSH with increased bioactivity. J Clin Endocrinol Metab 62:704-711
4. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638
5. Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J (1992) Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 75:540-546
6. Bevan JS, Burke CW, Esiri MM, Adams CB, Ballabio M, Nissim M, Faglia G (1989) Studies of two thyrotropin-secreting pituitary adenomas: evidence for dopamine deficiency. Clinical Endocrinol 31:59-70
7. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Cllin Endocrinol Metab 84:476-486
8. Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotroin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849-2853
9. Chanson P, Weingraub BD, Harris AG (1993) Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119:236-240
10. Comi R, Gesundheit N, Murray L, Gorden P, Weintraub BD (1987) Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 317:12-17
11. Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L, Cook DM (1992) Octreotide treatment of acromegaly: a randomized, multicenter study. Ann Int Med 117:711-718
12. Ezzat S, Horvath E, Harris AG, Kovacs K (1994) Morphological effects of octreotide on growth hormone- producing pituitary adenomas. J Clin Endocrinol Metab 79:113-118
13. Ezzat S, Horvath E, Kovacs K, Smyth HS, Sriger W, Asa SL (1995) Basic fibroblast growth factor expression by two prolactin and thyrotropin producing pituitary adenomas. Endocrin Pathol 6:125-134
14. Frawley LS, Boockfor FR (1991) Mammosomatotropes: Presence and functions in normal and neoplastic pituitary tissue. End Rev 12:337-355
15. Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson CH, Braverman LE, Oldfield EH, Weintraub BD (1989) Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity: case reports and follow -up of nine patients. Ann Intern Med 11:827-35
16. Greenman Y, Melmed S (1995) Thyrotropin-secreting pituitary tumors. In: Melmed S, ed, The pituitary. Blackwell, Boston, pp 546-558
17. Hill SA, Walko JM, Wilson CB, Hunt WE (1982) Thyrotropin-producing pituitary adenomas. J Neurosurg 57:515-519
18. McCutcheon IE, Weintraub BD, Oldfield EH (1990) Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 73:674-683
19. Mindermann T, Wilson CB (1993) Thyrotropin-producing pituitary adenomas. J Neurosurg 79:521-527
20. Radian S, Coculescu M, Morris JF (2003) Somatotroph to thyrotroph cell transdifferentiation during experimental hypothyroidism - a light and elecron-microscopy study. J Cell Mol Med 7:297-306
21. Sanno N, Teramoto A, Matsuno A, Osamura RY (1994) Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: Its multihormonality and expression of Pit- 1. Mod Pathol 7:893-899
22. Sanno N, Teramoto A, Matsuno A, Osamura RY (1995) Studies on GH and PRL gene expression by Non-radioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J Clin Endocrinol Metab 80:2518-2522
23. Sanno N, Teramoto A, Matsuno A, Osamura RY (1996) Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Arch Pathol Lab Med 120:73-77
24. Sanno N, Teramoto A, Osamura RY (2000) Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93:194-200
25. Sanno N, Osamura RY, Teramoto A, Horvath E, Kovacs K (2003) Pathology of pituitary tumors. Neurosurg Clin N Am 14:25-39
26. Stevenaert A, Harris AG, Kovacs K, Beckers A (1992) Presurgical octreotide treatment in acromegaly. Metabolism 41:51-58
27. Valdes Socin H, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433-442
28. Warnet A, Lajeunie E, Gelbert F, Duet M, Chanson P, Cophignon J, Harris AG (1991) Shrinkage of primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995). Acta Endocrinol 124:487-491
29. Wood DF, Johnston JM, Johnston DG (1991) Dopamine, the dopamine D2 receptor and pituitary tumors. Clin Endocrinol 35:455-466